Tweet The holygrail is specific targeting of disease causing immune cells whilst leaving the rest of the immune system intact and over the years I have seen alot of different approaches to the same problem. This is one more approach. We could do this very, very well and showed that depletion followed by tolerogenic antigen…
Month: November 2025
Stigma keeps many with chronic health issues in a hidden struggle
A third of adults live with chronic physical conditions such as multiple sclerosis (MS), but in most cases these conditions aren’t obvious to others — and many people downplay their […] The post Stigma keeps many with chronic health issues in a hidden struggle appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
High efficacy drugs are active in older people
Tweet There is a move to discountinue people fromdrugs once they age over 50 years old, here they looked at people with older age onset of MS and they saw that if people were treated with higher efficacy treatments they reponded better than lower efficacy treatment, There are risk benefits balance for every agent but…
Dear United States Government
Today, I am going to write something slightly unusual, but I think it is important. Regardless of where you live, I am sure everyone is aware that the United States Government has been shut down for X days. Both sides of the political aisle are blaming the other for the shutdown, and no matter who…
The Problem of the Investigator Led Study-Where Next
Tweet Ibudilast was shown to have a neuroprotective effect in the MS-SPRINT trial undertaken years ago and there was some benefit noted but the question we have to pose is, where is ibudilast… I think I can answer this and this is in the maggot pile… But it raises a serious question we have posed…
Q &A Novemeber 2025
Tweet Source: multiple-sclerosis-research.org